{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:18:00Z","timestamp":1790983080497,"version":"4.1.0"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7426-26","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:12:01Z","timestamp":1787609521000},"source":"Crossref","is-referenced-by-count":1,"title":["Concurrent Immune-related Enteritis and Cytomegalovirus Enteritis during Immune Checkpoint Inhibitor Therapy"],"prefix":"10.2169","author":[{"given":"Yuka","family":"Yamada","sequence":"first","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Toho University Ohashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Kodaka","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Toho University Ohashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Shinozawa","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Toho University Ohashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yokouchi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toho University Ohashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Matsuse","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Toho University Ohashi Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kim MK, Hwang SW. Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events. Clin Endosc 57: 725-734, 2024.","DOI":"10.5946\/ce.2024.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Venditti O, De Lisi D, Caricato M, et al. Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis. BMC Cancer 15: 87, 2015.","DOI":"10.1186\/s12885-015-1074-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mohamed Ali A, Richards JC, Boyle K, Faust G. Severe inflammatory ileitis resulting ileal perforation in association with combination immune checkpoint blockade for metastatic malignant melanoma. BMJ Case Rep 2018: bcr2018224913, 2018.","DOI":"10.1136\/bcr-2018-224913"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Anastasopoulou A, Samarkos M, Diamantopoulos P, et al. Cytomegalovirus infections in patients treated with immune checkpoint inhibitors for solid malignancies. Open Forum Infect Dis 10: ofad164, 2023.","DOI":"10.1093\/ofid\/ofad164"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kim S, Yoon KW, Gil E, Yoo K, Choi KJ, Park CM. Emergency gastrointestinal tract operation associated with cytomegalovirus infection. Ann Surg Treat Res 104: 119-125, 2023.","DOI":"10.4174\/astr.2023.104.2.119"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Anastasopoulou A, Samarkos M, Diamantopoulos P, et al. Cytomegalovirus infections in patients treated with immune checkpoint inhibitors. Open Forum Infect Dis 10: ofad164, 2023.","DOI":"10.1093\/ofid\/ofad164"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Burger RA, Brady MF, Bookman MA, et al. Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 32: 1210-1217, 2014.","DOI":"10.1200\/JCO.2013.53.6524"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hapani S, Chu D, Wu S. Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol 10: 559-568, 2009.","DOI":"10.1016\/S1470-2045(09)70112-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nicolaides S, Boussioutas A. Immune-related adverse events of the gastrointestinal system. Cancers (Basel) 15: 691, 2023.","DOI":"10.3390\/cancers15030691"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamada M, Abe T, Kubota S, et al. Cytomegalovirus-associated ulceration complicating immune checkpoint inhibitor-related colitis. Clin J Gastroenterol 19: 274-281, 2026.","DOI":"10.1007\/s12328-025-02263-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakai M, Kai Y, Suzuki K, et al. A case of perforated immune-related colitis complicated by cytomegalovirus infection during treatment of immune-related adverse effect in lung cancer immunotherapy. Respir Med Case Rep 41: 101794, 2022.","DOI":"10.1016\/j.rmcr.2022.101794"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7426-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:31:43Z","timestamp":1787974303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7426-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":11,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7426-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7426-26"}}